Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2012
10/11/2012US20120259008 Method for treating asthenopia
10/11/2012US20120259007 Anticoagulant compounds and their use
10/11/2012US20120259006 Novel benzofuran type derivatives, a composition comprising the same for treating or preventing cognitive dysfunction and the use thereof
10/11/2012US20120259005 BRCA1-Based Breast or Ovarian Cancer Prevention Agents and Methods of Use
10/11/2012US20120259004 Anti-cancer extract and compounds
10/11/2012US20120259003 Anti-wssv and/or tsv nucleic acid drug
10/11/2012US20120259002 Molecule for treating an inflammatory disorder
10/11/2012US20120259001 Duplex Oligonucleotides with Enhanced Functionality in Gene Regulation
10/11/2012US20120259000 Epidermal differentiation microrna signature and uses thereof
10/11/2012US20120258999 Reagents, Methods and Systems to Suppress Pro-Inflammatory Cytokines
10/11/2012US20120258998 Fusion genes in gastrointestinal cancer
10/11/2012US20120258997 New application of 2-pyrrolidone derivatives
10/11/2012US20120258996 Novel ligands that modulate rar receptors
10/11/2012US20120258995 New Indolinone Protein Kinase Inhibitors
10/11/2012US20120258994 Preparation and Use of (+)-1-(3,4-Dichlorophenyl)-3-Azabicyclo[3.1.0]Hexane In The Treatment of Conditions Affected by Monoamine Neurotransmitters
10/11/2012US20120258993 Non-natural macrocyclic amide hdac6 inhibitor compounds and their uses as therapeutic agents
10/11/2012US20120258992 Dual-acting antihypertensive agents
10/11/2012US20120258991 Method of treating a cancer by administering a specified drug
10/11/2012US20120258988 Therapeutic or prophylactic agent for diabetes
10/11/2012US20120258987 Lysophosphatidic acid receptor antagonists
10/11/2012US20120258986 Olefin containing nuclear transport modulators and uses thereof
10/11/2012US20120258985 Stabilized polymeric thiol reagents
10/11/2012US20120258984 5-htp combination therapy
10/11/2012US20120258983 Pharmaceutical Composition and Administrations Thereof
10/11/2012US20120258982 Adamantyl compounds
10/11/2012US20120258981 Process for the Synthesis of Quaternary Amine Compounds
10/11/2012US20120258980 Antibacterial Agent for Drug-Resistant Bacteria, Method for Screening for Same, and Use of Same
10/11/2012US20120258979 Substituted piperidine spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
10/11/2012US20120258978 Nitrogen-containing six-membered aromatic ring derivatives and pharmaceutical products containing the same
10/11/2012US20120258977 Inhibitors of e1 activating enzymes
10/11/2012US20120258976 Crystalline pyrrolo[2,3-d]pyrimidine compounds
10/11/2012US20120258975 Potent Small Molecule Inhibitors of Autophagy, and Methods of Use Thereof
10/11/2012US20120258974 Use of a2b adenosine receptor antagonists for treating heart failure and arrhythmia in post-myocardial infarction patients
10/11/2012US20120258973 Disubstituted heteroaryl-fused pyridines
10/11/2012US20120258972 Composition and Methods for Treating Hair Loss
10/11/2012US20120258971 Therapeutic agent for chronic pain
10/11/2012US20120258970 Compositions and Methods for the Treatment of Drug-Induced Hand-Foot Syndrome
10/11/2012US20120258969 Viral inhibitors
10/11/2012US20120258968 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity
10/11/2012US20120258967 Pi3 kinase inhibitors and uses thereof
10/11/2012US20120258966 Pharmaceutical compounds
10/11/2012US20120258965 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors
10/11/2012US20120258964 2-heteroaryl carboxamides
10/11/2012US20120258963 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
10/11/2012US20120258962 1,3-oxazines as bace1 and/or bace2 inhibitors
10/11/2012US20120258961 4-amino-1,3-thiazine or oxazine derivative
10/11/2012US20120258960 Novel multifunctional peptidase inhibitors, especially for medical use
10/11/2012US20120258959 Pyridone gpr119 g protein-coupled receptor agonists
10/11/2012US20120258958 Azaindoles useful as inhibitors of jak and other protein kinases
10/11/2012US20120258957 Heterocyclic derivatives
10/11/2012US20120258956 Use of a spirolide, analogues and derivatives for treating and/or preventing pathological conditions linked to the tau and beta-amyloid proteins
10/11/2012US20120258955 Bicyclic thiazoles as allosteric modulators of mglur5 receptors
10/11/2012US20120258954 ArylSulfonamide Based Matrix Metalloprotease Inhibitors
10/11/2012US20120258953 Benzoxazepines as Inhibitors of PI3K/mTOR and Methods of Their Use and Manufacture
10/11/2012US20120258952 Substituted N-(1H-Indazol-4-yl)Imidazo[1,2-a]Pyridine-3-Carboxamide Compounds as cFMS Inhibitors
10/11/2012US20120258951 Novel antiplatelet agent
10/11/2012US20120258950 PYRROLO[2,3-d]PYRIMIDINE TROPOMYSIN-RELATED KINASE INHIBITORS
10/11/2012US20120258949 Spirocyclic derivatives as histone deacetylase inhibitors
10/11/2012US20120258948 N-Linked Hydroxamic Acid Derivatives Useful As Antibacterial Agents
10/11/2012US20120258947 Substituted 6-amino-nicotinamides as kcnq2/3 modulators
10/11/2012US20120258946 Substituted Phenylureas and Phenylamides as Vanilloid Receptor Ligands
10/11/2012US20120258945 Association Between Ferroquine and an Artemisinine Derivative for Treating Malaria
10/11/2012US20120258944 Antioxidants for use in therapy
10/11/2012US20120258943 Formulations of deoxycholic acid and salts thereof
10/11/2012US20120258942 Device for transdermal administration of drugs including acrylic polymers
10/11/2012US20120258941 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases
10/11/2012US20120258940 Method for treating haematological cancers
10/11/2012US20120258939 Pharmaceutical manufacturing process
10/11/2012US20120258938 Enzymatic Production or Chemical Synthesis and Uses for 5,7-Dienes and UVB Conversion Products Thereof
10/11/2012US20120258937 Targeting Estrogen Receptors in the Treatment of Lymphangioleiomyomatosis
10/11/2012US20120258936 Inositol hexakisphosphate analogs and uses thereof
10/11/2012US20120258935 Process for preparation of hiv protease inhbitors
10/11/2012US20120258934 Fosfomycin pharmaceutical composition
10/11/2012US20120258933 Combination
10/11/2012US20120258932 Combination of polychitosamine and hmg-coa reductase inhibitor for hyperlipidemia
10/11/2012US20120258931 Regimens for Intra-Articular Viscosupplementation
10/11/2012US20120258930 The Improvement of Gastrointestinal Health, Immunity and Performance by Dietary Intervention
10/11/2012US20120258928 Nucleoside cyclicphosphates
10/11/2012US20120258927 Inhibitors of e1 activating enzymes
10/11/2012US20120258926 Formulations of acadesine
10/11/2012US20120258925 Antibacterial aminoglycoside analogs
10/11/2012US20120258924 Method of modulating stress-activated protein kinase system
10/11/2012US20120258923 BIOACTIVITY COMPOSITION OF Reevesia formosana
10/11/2012US20120258922 Synergistic inhibition of low-density lipoprotein oxidation
10/11/2012US20120258918 Polypeptoid pulmonary surfactants
10/11/2012US20120258913 Glucopyranoside compound
10/11/2012US20120258911 Phenylalkylcarboxylic acid delivery agents
10/11/2012US20120258453 Nucleic acid probe-based diagnostic assays targeting ssra genes of prokaryotic and eukaryotic organisms
10/11/2012US20120258185 Hair care compositions, methods, and articles of commerce that can increase the appearance of thicker and fuller hair
10/11/2012US20120258184 Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and food or beverage
10/11/2012US20120258182 Synergistic compositions and methods
10/11/2012US20120258181 Anticancer combination of artemisinin-based drugs and other chemotherapeutic agents
10/11/2012US20120258180 Parp inhibitors for the treatment of cipn
10/11/2012US20120258177 Microcapsules comprising benzoyl peroxide and topical compositions comprising them
10/11/2012US20120258176 Nanoparticles for protein drug delivery
10/11/2012US20120258174 Methods for Treating Bacterial Infection
10/11/2012US20120258173 Functionally-Coated Multilayer Tablets
10/11/2012US20120258171 Composition comprising fesoterodine and fiber
10/11/2012US20120258170 Pharmaceutical co-crystals of quercetin
10/11/2012US20120258167 Oral pharmaceutical composition
1 ... 1004 1005 1006 1007 1008 1009 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 ... 7860